Lidocaine HCl 2% 5 mL, Syringe, Rx Only, SCA Pharmaceuticals 755 Rainbow Road Windsor, CT 08695 NDC 70004-0723-09
Published December 18, 2019 · Recall initiated: November 26, 2019
Summary
FDA records drug Class II recall D-0620-2020, published December 18, 2019 and initiated November 26, 2019. Recalling firm: SCA Pharmaceuticals, LLC; Status: Terminated; Reported quantity: 1363 syringes; Lot: 1219012595 29-Dec-19 1219012647 01-Jan-20. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Foreign Substance: Foreign material found inside the vial (manufacturer).
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- SCA Pharmaceuticals, LLC
- Distributor
- nationwide
- Lot
- 1219012595 29-Dec-19 1219012647 01-Jan-20
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAlabetalol HCl 20 mg/4mL Injection, (Concentration=5 mg/mL), 4 mL fill Syringe, Rx Only, SCA Pharma, 755April 3, 2024
- FDAHYDROmorphone HCl 30 mg/30 mL in 0.9% Sodium Chloride Injection, (Concentration = 1mg/mL) 30 mL fill Syringe,April 3, 2024
- FDAPHENYLephrine HCl 5000 mcg/50 mL in 0.9% Sodium Chloride Injection, (Concentration = 100 mcg/mL), 50 mLApril 3, 2024
- FDAPHENYLephrine HCl 40 mg in 0.9% Sodium Chloride Injection, (Concentration = 160 mcg/mL), 250 mL Bag, Rx Only,April 3, 2024
- FDARanitidine Tablets, USP 150 mg, OTC, a.) 30 count bottle (NDC 68788-7078-03), b.) 60 count bottle (NDCDecember 18, 2019
- FDAMirtazapine Tablets, USP, 15 mg, 500-count tablets, Rx only, Distributed by: Aurobindo Pharma USA, Inc.December 18, 2019
Questions about this recall
Was Lidocaine HCl 2% 5 mL, Syringe, Rx Only, SCA Pharmaceuticals 755 Rainbow Road Windsor, CT 08695 NDC 70004-0723-09 recalled?
Yes. FDA published recall D-0620-2020 on December 18, 2019. Reported hazard: Presence of Foreign Substance: Foreign material found inside the vial (manufacturer).
What should I do if I have this product?
Voluntary: Firm initiated · Letter